Galapagos

Galapagos

Foundation date

30/06/1999

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Small molecules
• #Therapeutics - Antibodies

Therapeutic areas

• #Diseases of the blood and blood-forming organs - immune disorders
• #Infectious and parasitic diseases
• #Musculoskeletal system and connective tissue
• #Neoplasms / cancer / oncology
• #Respiratory system

Galapagos seeks to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to revolutionize existing treatment paradigms. Our ambition is to become a leading global biotechnological company, focused on the development and commercialization of novel medicines that will improve people’s lives.